Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 15, 2017
Total Value: $1.643B (98.4% shares, 1.6% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 16,093,786 | $135M | 8.2% | $5.55 | — | COM | 04269X105 |
| FOLD | AMICUS THERAPEUTICS INC | 12,043,932 | $121M | 7.4% | $7.18 | +12.0% | COM | 03152W109 |
| PEN | PENUMBRA INC | 931,444 | $81.73M | 5.0% | $49.77 | +70.7% | COM | 70975L107 |
| PBYI | PUMA BIOTECHNOLOGY INC | 860,456 | $75.2M | 4.6% | $44.35 | +26.1% | COM | 74587V107 |
| — | CLOVIS ONCOLOGY INC | 764,389 | $71.57M | 4.4% | $34.31 | — | COM | 189464100 |
| — | JUNO THERAPEUTICS INC | 2,219,616 | $66.34M | 4.0% | $29.89 | — | COM | 48205A109 |
| MOH | MOLINA HEALTHCARE INC | 828,574 | $57.32M | 3.5% | $54.71 | +12.2% | COM | 60855R100 |
| — | INC RESH HLDGS INC | 841,418 | $49.22M | 3.0% | $48.97 | — | CL A | 45329R109 |
| — | GW PHARMACEUTICALS PLC | 444,936 | $44.6M | 2.7% | $124.53 | — | ADS | 36197T103 |
| ELV | ANTHEM INC | 231,886 | $43.63M | 2.7% | $138.45 | +15.8% | COM | 036752103 |
| WVE | WAVE LIFE SCIENCES LTD | 2,224,407 | $41.37M | 2.5% | $21.84 | -1.3% | SHS | Y95308105 |
| — | ATARA BIOTHERAPEUTICS INC | 2,734,044 | $38.28M | 2.3% | $23.48 | — | COM | 046513107 |
| — | IMMUNOGEN INC | 5,212,736 | $37.06M | 2.3% | $4.63 | — | COM | 45253H101 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 2,155,949 | $36.26M | 2.2% | $14.48 | — | ORD SHS | G6855A103 |
| AGIO | AGIOS PHARMACEUTICALS INC | 681,165 | $35.05M | 2.1% | $44.35 | +15.3% | COM | 00847X104 |
| — | SEATTLE GENETICS INC | 665,139 | $34.41M | 2.1% | $41.29 | — | COM | 812578102 |
| RGNX | REGENXBIO INC | 1,718,671 | $33.94M | 2.1% | $19.31 | +0.3% | COM | 75901B107 |
| CNC | CENTENE CORP DEL | 398,200 | $31.81M | 1.9% | $37.75 | 0.0% | COM | 15135B101 |
| — | ENDOLOGIX INC | 6,368,299 | $30.95M | 1.9% | $6.45 | — | COM | 29266S106 |
| BSX | BOSTON SCIENTIFIC CORP | 1,094,983 | $30.35M | 1.8% | $21.87 | +21.4% | COM | 101137107 |
| — | AUDENTES THERAPEUTICS INC | 1,459,616 | $27.92M | 1.7% | $17.52 | — | COM | 05070R104 |
| PRTA | PROTHENA CORP PLC | 509,698 | $27.59M | 1.7% | $48.00 | +11.0% | SHS | G72800108 |
| EW | EDWARDS LIFESCIENCES CORP | 218,000 | $25.78M | 1.6% | $36.50 | 0.0% | COM | 28176E108 |
| — | ARRAY BIOPHARMA INC | 19,000,000 | $25.66M | 1.6% | $1.31 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | ALDER BIOPHARMACEUTICALS INC | 2,223,811 | $25.46M | 1.6% | $23.26 | — | COM | 014339105 |
| XNCR | XENCOR INC | 1,187,494 | $25.07M | 1.5% | $24.07 | -6.9% | COM | 98401F105 |
| — | SPECTRANETICS CORP | 634,802 | $24.38M | 1.5% | $27.18 | — | COM | 84760C107 |
| EHTH | EHEALTH INC | 1,223,334 | $23M | 1.4% | $10.57 | +51.0% | COM | 28238P109 |
| — | CHIMERIX INC | 4,207,575 | $22.93M | 1.4% | $4.50 | — | COM | 16934W106 |
| ICUI | ICU MED INC | 132,505 | $22.86M | 1.4% | $146.16 | +9.8% | COM | 44930G107 |
| — | LA JOLLA PHARMACEUTICAL CO | 713,280 | $21.23M | 1.3% | $29.84 | — | COM PAR $.0001 2 | 503459604 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 476,341 | $20.24M | 1.2% | $36.42 | 0.0% | COM | 450056106 |
| — | BLUEPRINT MEDICINES CORP | 367,537 | $18.62M | 1.1% | $39.99 | — | COM | 09627Y109 |
| VRTX | VERTEX PHARMACEUTICALS INC | 144,408 | $18.61M | 1.1% | $120.38 | 0.0% | COM | 92532F100 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 631,283 | $17.27M | 1.1% | $29.26 | — | COM | 37890U108 |
| — | NEURODERM LTD | 555,096 | $16.6M | 1.0% | $21.26 | — | ORD SHS | M74231107 |
| — | NXSTAGE MEDICAL INC | 657,356 | $16.48M | 1.0% | $25.07 | — | COM | 67072V103 |
| — | JOUNCE THERAPEUTICS INC | 1,138,370 | $15.97M | 1.0% | $20.08 | — | COM | 481116101 |
| — | SYROS PHARMACEUTICALS INC | 973,260 | $15.66M | 1.0% | $15.70 | — | COM | 87184Q107 |
| — | NANOSTRING TECHNOLOGIES INC | 866,819 | $14.34M | 0.9% | $13.81 | — | COM | 63009R109 |
| — | CLOVIS ONCOLOGY INC | 152,000 | $14.23M | 0.9% | $34.31 | — | Call | 189464100 |
| — | CASCADIAN THERAPEUTICS INC | 3,735,994 | $13.88M | 0.8% | $4.14 | — | COM NEW | 14740B606 |
| LIVN | LIVANOVA PLC | 212,028 | $12.98M | 0.8% | $56.55 | 0.0% | SHS | G5509L101 |
| — | MODEL N INC | 858,314 | $11.42M | 0.7% | $10.78 | — | COM | 607525102 |
| CTMX | CYTOMX THERAPEUTICS INC | 698,392 | $10.82M | 0.7% | $15.81 | -4.6% | COM | 23284F105 |
| — | PUMA BIOTECHNOLOGY INC | 101,500 | $8.871M | 0.5% | — | — | Call | 74587V907 |
| PRQR | PROQR THRAPEUTICS N V | 1,596,275 | $8.301M | 0.5% | $8.87 | -43.9% | SHS EURO | N71542109 |
| — | INVITAE CORP | 812,240 | $7.765M | 0.5% | $8.48 | — | COM | 46185L103 |
| — | GLYCOMIMETICS INC | 599,620 | $6.692M | 0.4% | $11.16 | — | COM | 38000Q102 |
| MEDP | MEDPACE HLDGS INC | 225,040 | $6.526M | 0.4% | $28.05 | 0.0% | COM | 58506Q109 |
| — | CATALENT INC | 145,963 | $5.123M | 0.3% | $28.32 | — | COM | 148806102 |
| FATE | FATE THERAPEUTICS INC | 1,419,058 | $4.598M | 0.3% | $5.74 | -33.3% | COM | 31189P102 |
| OVID | OVID THERAPEUTICS INC | 448,781 | $4.237M | 0.3% | $13.06 | 0.0% | COM | 690469101 |
| ACRS | ACLARIS THERAPEUTICS INC | 94,560 | $2.564M | 0.2% | $25.57 | +6.3% | COM | 00461U105 |
| AUPH | AURINIA PHARMACEUTICALS INC | 332,310 | $2.037M | 0.1% | $5.63 | +19.7% | COM | 05156V102 |
| UNH | UNITEDHEALTH GROUP INC | 1,820 | $337K | 0.0% | $120.51 | +26.7% | COM | 91324P102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 6,640 | $305K | 0.0% | $42.84 | +13.2% | COM | 64125C109 |
| — | ALLERGAN PLC | 1,200 | $292K | 0.0% | $243.33 | — | SHS | G0177J108 |
| — | NEKTAR THERAPEUTICS | 14,580 | $285K | 0.0% | $19.55 | — | COM | 640268108 |
| INSM | INSMED INC | 12,380 | $212K | 0.0% | $17.08 | 0.0% | COM PAR $.01 | 457669307 |
| — | AMEDISYS INC | 3,356 | $211K | 0.0% | $51.18 | — | COM | 023436108 |
| BKD | BROOKDALE SR LIVING INC | 12,110 | $178K | 0.0% | $13.82 | 0.0% | COM | 112463104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 22,236 | $56,000 | 0.0% | $3.15 | — | COM | 00773U108 |
| — | CASTLIGHT HEALTH INC | 10,229 | $42,000 | 0.0% | $4.01 | — | CL B | 14862Q100 |